Anlotinib for the treatment of recurrent and refractory hemangioblastomas: a case report and review of literature
{{output}}
Hemangioblastomas (HBs) are rare, highly vascular tumors that present significant treatment challenges, especially in cases of multiple recurrences. Here we present our experience treating one patient with recurrent and refractory HBs, aiming to provide prelim... ...